Candriam Equities L Oncology Impact C/ LU1864484214 /
| NAV2024-05-16 | Chg.-0.0800 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 245.4500EUR | -0.03% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-05-21 | Public WebStation Live Factsheet | 2024 | English | - |
| 2024-03-01 | PRIIP Key Information Document | 2024 | German | 268.65 KB |
| 2023-12-31 | Account statment | 2023 | English | 5,416.37 KB |
| 2023-12-31 | Account statment | 2023 | German | 4,732.66 KB |
| 2023-09-11 | Prospectus | 2023 | English | 3,638.77 KB |
| 2023-09-11 | Prospectus | 2023 | German | 3,801.35 KB |
| 2023-06-30 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 2023-06-30 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 2022-07-02 | Key Investor Information | 2022 | German | 362.88 KB |
